Groupon Inc (NASDAQ:GRPN) isn’t dead, despite general sluggishness in its flagship daily-deals model. The fallen dot-com darling may be trading well below its 2011 IPO price of $20, but Groupon Inc (NASDAQ:GRPN)’s been able to expand its breadth of services to the local merchants that it’s been servicing.
Analysts see an uptick in profitability and a modest gain in revenue.
Finally, we have Dendreon Corporation (NASDAQ:DNDN). The drugmaker behind Provenge — an expensive yet intriguing treatment for late-stage prostate cancer — excited investors with a sequential uptick in its flagship drug in its most recent quarter, but it did warn of softness for the quarter that it will be reporting on come Thursday.
Wall Street’s holding out for a narrowing quarterly loss, though naturally it will also want to know which way Provenge sales have been trending.
Cross those fingers, but know the fundamentals
Investors in these five stocks have a right to be excited. They are all improving their financial situations. They are worthy of the gains that the market rally has bestowed upon them over the past year.
I wouldn’t be uncomfortable owning any of these companies. They’re doing the right thing, regardless of Mr. Market’s mood swings.
The expectations may be high, but these five stocks wouldn’t have it any other way.
The article 5 Reasons Not to Worry This Week originally appeared on Fool.com.
Longtime Fool contributor Rick Munarriz owns shares of Sodastream International Ltd (NASDAQ:SODA). The Motley Fool recommends MAKO Surgical Corp. (NASDAQ:MAKO) and SodaStream. The Motley Fool owns shares of Dendreon Corporation (NASDAQ:DNDN), Heckmann Corporation (NYSE:HEK), and SodaStream and has the following options: Long Jan 2014 $4 Calls on Heckmann and Short Jan 2014 $3 Puts on Heckmann Corporation (NYSE:HEK).
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.